Quadax Discusses Early Results of Prior Authorization at Molecular Med Tri-Con

February 6, 2018

Responsive image

CLEVELAND, Feb. 6, 2018 /PRNewswire/ — Quadax Inc., a leader in healthcare revenue cycle optimization software and services, is a corporate sponsor for the Molecular Med Tri-Con conference taking place at the Hilton San Francisco Union Square from February 11-16, 2018.

Category: Precious Metals